Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Stowe

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
CPT: Pharmacometrics & Systems Pharmacology|January 20, 2024
Virtual twins for model-informed precision dosing of clozapine in patients with treatment-resistant schizophreniaSam Mostafa, Reza Rafizadeh, Thomas M Polasek, et al.
Neuroscience Letters|July 15, 2009
MK801-induced activated caspase-3 exhibits selective co-localization with GAD67Christopher P Turner, Danielle Debenedetto, Emily Ware, et al.
The Pharmacogenomics Journal|April 24, 2022
Whole-genome sequencing analysis of clozapine-induced myocarditisAnkita Narang, Paul Lacaze, Kathlyn J Ronaldson, et al.
Medrxiv : the Preprint Server for Health Sciences|June 4, 2025
Medical Multimorbidity in Patients with Treatment-Resistant Psychosis and Rare Copy Number Variants: A Retrospective Case Series of 24 PatientsTyler E Dietterich, Rose Mary Xavier, Maya L Lichtenstein, et al.
American Journal of Medical Genetics. Part A|August 1, 2025
Medical Multimorbidity in Patients With Treatment-Resistant Psychosis and Rare Copy Number Variants: A Retrospective Case Series of 24 PatientsTyler E Dietterich, Rose Mary Xavier, Maya L Lichtenstein, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|August 1, 2025
Delineating lifetime multimorbidity associated with 16p13.11 duplication: A literature review, meta-analysis, and case studyRose Mary Xavier, Wenxin Bian, Fadhah Alshammari, et al.
The American Journal of Psychiatry|May 2, 2018
Developmental Delay, Treatment-Resistant Psychosis, and Early-Onset Dementia in a Man With 22q11 Deletion Syndrome and Huntington's DiseaseMartilias Farrell, Maya Lichtenstein, James J Crowley, et al.
Schizophrenia Research|September 18, 2020
Treatment-resistant psychotic symptoms and early-onset dementia: A case report of the 3q29 deletion syndromeMatthew K Harner, Maya Lichtenstein, Martilias Farrell, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
CPT: Pharmacometrics & Systems Pharmacology|January 20, 2024
Virtual twins for model-informed precision dosing of clozapine in patients with treatment-resistant schizophreniaSam Mostafa, Reza Rafizadeh, Thomas M Polasek, et al.
Neuroscience Letters|July 15, 2009
MK801-induced activated caspase-3 exhibits selective co-localization with GAD67Christopher P Turner, Danielle Debenedetto, Emily Ware, et al.
The Pharmacogenomics Journal|April 24, 2022
Whole-genome sequencing analysis of clozapine-induced myocarditisAnkita Narang, Paul Lacaze, Kathlyn J Ronaldson, et al.
Medrxiv : the Preprint Server for Health Sciences|June 4, 2025
Medical Multimorbidity in Patients with Treatment-Resistant Psychosis and Rare Copy Number Variants: A Retrospective Case Series of 24 PatientsTyler E Dietterich, Rose Mary Xavier, Maya L Lichtenstein, et al.
American Journal of Medical Genetics. Part A|August 1, 2025
Medical Multimorbidity in Patients With Treatment-Resistant Psychosis and Rare Copy Number Variants: A Retrospective Case Series of 24 PatientsTyler E Dietterich, Rose Mary Xavier, Maya L Lichtenstein, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|August 1, 2025
Delineating lifetime multimorbidity associated with 16p13.11 duplication: A literature review, meta-analysis, and case studyRose Mary Xavier, Wenxin Bian, Fadhah Alshammari, et al.
The American Journal of Psychiatry|May 2, 2018
Developmental Delay, Treatment-Resistant Psychosis, and Early-Onset Dementia in a Man With 22q11 Deletion Syndrome and Huntington's DiseaseMartilias Farrell, Maya Lichtenstein, James J Crowley, et al.
Schizophrenia Research|September 18, 2020
Treatment-resistant psychotic symptoms and early-onset dementia: A case report of the 3q29 deletion syndromeMatthew K Harner, Maya Lichtenstein, Martilias Farrell, et al.
Pageof 2